2060 related articles for article (PubMed ID: 31378236)
21. [Immunotherapy and multidisciplinary approach to treatment in lung cancer].
Karadurmuş N; Kaya A; Göksel T; Yılmaz Ü; Tülek N
Tuberk Toraks; 2020 Mar; 68(1):66-75. PubMed ID: 32718141
[TBL] [Abstract][Full Text] [Related]
22. Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer.
Drake JA; Portnoy DC; Tauer K; Weksler B
Ann Thorac Surg; 2018 Oct; 106(4):959-965. PubMed ID: 29856974
[TBL] [Abstract][Full Text] [Related]
23. The estrogen pathway as a modulator of response to immunotherapy.
Velez MA; Burns TF; Stabile LP
Immunotherapy; 2019 Sep; 11(13):1161-1176. PubMed ID: 31361169
[TBL] [Abstract][Full Text] [Related]
24. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
25. Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers.
Misumi K; Harada H; Tsubokawa N; Tsutani Y; Matsumoto K; Miyata Y; Yamashita Y; Okada M
Gen Thorac Cardiovasc Surg; 2017 Jul; 65(7):392-399. PubMed ID: 28432576
[TBL] [Abstract][Full Text] [Related]
26. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Ramnath N; Dilling TJ; Harris LJ; Kim AW; Michaud GC; Balekian AA; Diekemper R; Detterbeck FC; Arenberg DA
Chest; 2013 May; 143(5 Suppl):e314S-e340S. PubMed ID: 23649445
[TBL] [Abstract][Full Text] [Related]
27. Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.
Soo RA; Lim SM; Syn NL; Teng R; Soong R; Mok TSK; Cho BC
Lung Cancer; 2018 Jan; 115():12-20. PubMed ID: 29290252
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.
Giroux Leprieur E; Dumenil C; Julie C; Giraud V; Dumoulin J; Labrune S; Chinet T
Eur J Cancer; 2017 Jun; 78():16-23. PubMed ID: 28407528
[TBL] [Abstract][Full Text] [Related]
29. Evaluation and treatment of patients with non-small cell lung cancer.
Carr LL; Finigan JH; Kern JA
Med Clin North Am; 2011 Nov; 95(6):1041-54. PubMed ID: 22032426
[TBL] [Abstract][Full Text] [Related]
30. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
[TBL] [Abstract][Full Text] [Related]
31. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
[TBL] [Abstract][Full Text] [Related]
32. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
Schroeder MC; Tien YY; Wright K; Halfdanarson TR; Abu-Hejleh T; Brooks JM
Lung Cancer; 2016 May; 95():28-34. PubMed ID: 27040848
[TBL] [Abstract][Full Text] [Related]
33. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
34. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Hsu PC; Jablons DM; Yang CT; You L
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
[TBL] [Abstract][Full Text] [Related]
35. The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.
Rhodin KE; Rucker AJ; Ready NE; D'Amico TA; Antonia SJ
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1616-1623. PubMed ID: 31836182
[TBL] [Abstract][Full Text] [Related]
36. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
Alden RS; Mandrekar SJ; Oxnard GR
Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
[TBL] [Abstract][Full Text] [Related]
37. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
[TBL] [Abstract][Full Text] [Related]
38. Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer.
Adderley H; Blackhall FH; Lindsay CR
Cancer Immunol Immunother; 2021 Mar; 70(3):589-595. PubMed ID: 32915318
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506).
Song Y; Zhou Q; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Yao LD; Zhan LJ; Yang F; Wu YL
Lung Cancer; 2018 Sep; 123():7-13. PubMed ID: 30089597
[TBL] [Abstract][Full Text] [Related]
40. Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer.
Villar Álvarez F; Muguruza Trueba I; Belda Sanchis J; Molins López-Rodó L; Rodríguez Suárez PM; Sánchez de Cos Escuín J; Barreiro E; Borrego Pintado MH; Disdier Vicente C; Flandes Aldeyturriaga J; Gámez García P; Garrido López P; León Atance P; Izquierdo Elena JM; Novoa Valentín NM; Rivas de Andrés JJ; Royo Crespo Í; Salvatierra Velázquez Á; Seijo Maceiras LM; Solano Reina S; Aguiar Bujanda D; Avila Martínez RJ; de Granda Orive JI; de Higes Martinez E; Diaz-Hellín Gude V; Embún Flor R; Freixinet Gilart JL; García Jiménez MD; Hermoso Alarza F; Hernández Sarmiento S; Honguero Martínez AF; Jimenez Ruiz CA; López Sanz I; Mariscal de Alba A; Martínez Vallina P; Menal Muñoz P; Mezquita Pérez L; Olmedo García ME; Rombolá CA; San Miguel Arregui I; de Valle Somiedo Gutiérrez M; Triviño Ramírez AI; Trujillo Reyes JC; Vallejo C; Vaquero Lozano P; Varela Simó G; Zulueta JJ
Arch Bronconeumol; 2016 Jul; 52(7):378-88. PubMed ID: 27237592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
